Lecanemab for Alzheimer's disease: tempering hype and hope.
Lancet. 2022 Dec 3;400(10367):1899. doi: 10.1016/S0140-6736(22)02480-1.
Lancet. 2022.
PMID: 36463893
No abstract available.